Literature DB >> 12744601

Synthesis and biological activity of 2-aminopurine methylenecyclopropane analogues of nucleosides.

Ruifang Wang1, Xinchao Chen, John C Drach, Earl R Kern, Jiri Zemlicka.   

Abstract

Synthesis and biological activity of racemic 2-aminopurine methylenecyclopropane analogues of nucleosides 4, 5, 10 and 11 is described. One-pot alkylation-elimination of 2-aminopurine (6) with dibromide 7 gave a mixture of four isomeric methylenecyclopropanes. The (E, Z)-N9 and (E, Z)-N7 isomers 8 and 9 were resolved by chromatography on silica gel. Deacetylation of 8 afforded the respective (Z)-N9 and (E)-N9 isomers 4 and 10 which were separated by chromatography on silica gel. In a similar fashion, (E, Z)-N7 mixture 9 furnished (Z)-N7 and (E)-N7 isomers 5 and 11. The S-(+)-enantiomer 4 was obtained by desulfurization of (S)-(+)-6-thiosynguanol (13) with Raney Ni. Compound 13 was obtained from (S)-(+)-2-amino-6-chloro derivative 12 and NaSH in methanol. Racemic analogues 4, 5, 10 and 11 were inactive against HCMV, HSV-1, HSV-2, EBV and VZV. Enantiomer (S)-(+)-4 inhibited replication of HSV-1 in BSC-1 cells (ELISA) with EC50 35 microM and it was non-cytotoxic in KB cells (CC50 > 100 microM). Compound (S)-(+)-4 was also moderately effective against VZV in HFF culture with EC50/CC50 (microM) 60/>460 and it was a substrate for xanthine oxidase.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12744601     DOI: 10.1081/NCN-120019502

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  2 in total

1.  Stereoselective approach to the Z-isomers of methylenecyclopropane analogues of nucleosides: a new synthesis of antiviral synguanol.

Authors:  Zhimeng Wu; Shaoman Zhou; Jiri Zemlicka
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2009-03       Impact factor: 1.381

2.  Synthesis and antiviral activity of 6-deoxycyclopropavir, a new prodrug of cyclopropavir.

Authors:  Chengwei Li; Debra C Quenelle; Mark N Prichard; John C Drach; Jiri Zemlicka
Journal:  Bioorg Med Chem       Date:  2012-02-20       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.